| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 01/20/2011 | US20110015164 Method of treating men with metabolic and anthropometric disorders |
| 01/20/2011 | US20110013124 Lyotropic chromophoric compounds, liquid crystal systems and optically anisotropic films |
| 01/20/2011 | CA2768236A1 (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof |
| 01/19/2011 | EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds |
| 01/19/2011 | EP1644336B1 Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin |
| 01/19/2011 | CN1816543B Indole derivatives with apoptosis-inducing effect |
| 01/19/2011 | CN101948430A Sinomenine derivative and preparation method and applications thereof |
| 01/19/2011 | CN101948429A 1-methyl-7H-indene[1, 2-b]quinolinetrifluoromesylate-7-(4-dimethylamino) benzyl alkene derivant and preparation thereof |
| 01/19/2011 | CN101948428A 1-methyl-5H-indene (1,2-b) pyridine trifluoromethanesulfonic salt-5-(4-dimethylamino group) benzylidene derivative and preparation method thereof |
| 01/19/2011 | CN101948427A Method for converting diester aconitum alkaloids into talatisamine alkaloids |
| 01/19/2011 | CN101092397B Structure modified compound of sinomenine, and prepartion method |
| 01/18/2011 | US7872135 Method for introducing a 1,2-double bond into 3-oxo-4-azasteroid compounds |
| 01/13/2011 | US20110009628 Compounds and Compositions for Modulating Lipid Levels and Methods of Preparing Same |
| 01/13/2011 | US20110009622 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient |
| 01/13/2011 | US20110009442 Methods for stereoselective reduction |
| 01/13/2011 | US20110009441 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| 01/13/2011 | US20110009371 Synthesis of tetracyclines and analogues thereof |
| 01/12/2011 | EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds |
| 01/12/2011 | EP2271626A1 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors |
| 01/12/2011 | EP1682138B1 Heterocyclic inhibitors of mek |
| 01/11/2011 | US7868173 Prodrugs of benzoquinolizine-2-carboxylic acid |
| 01/11/2011 | US7868017 Monoamine reuptake inhibitors such as exo-3-(benzo[d]isothiazol-7-yloxy)-9-azabicyclo[3.3.1]nonane, used as antidepressants, anxiolytic agents and analgesics, or for the treatment of obsessive compulsive disorder |
| 01/11/2011 | CA2468824C Hexacyclic compounds |
| 01/11/2011 | CA2451678C Azaindoles |
| 01/11/2011 | CA2422054C Bicyclic heteroaromatic compounds |
| 01/11/2011 | CA2372063C Pyridopyranoazepine derivatives, their preparation and their therapeutic application |
| 01/06/2011 | WO2010129057A3 Tetracycline compounds |
| 01/05/2011 | EP2268618A1 Compounds and compositions as tlr activity modulators |
| 01/05/2011 | CN101935302A Asymmetric synthetic method of (-)-huperzine key intermediate |
| 01/05/2011 | CN101010406B New compound and organic light emitting device using the same (6) |
| 01/05/2011 | CN101010405B New compound and organic light emitting device using the same(8) |
| 01/04/2011 | US7863292 modulators of hypoxia inducible factors and/or endogenous erythropoietin, such as 1-Chloro-4-hydroxy-7-isopropoxy-isoquinoline-3-carboxylic acid (2-hydroxy-1-hydroxymethyl-ethyl)-amide, used for the treatment of anemic disorders, neurological disorders and/or injuries |
| 01/04/2011 | US7862908 8,8-Bis-(4-tert-butyl-phenyl)-8H-indolo[3,2,1-de]acridine; host material, electron/hole transport material in organic electronic devices; high heat resistance to increase lifetime; high triplet-state energy difference; can be used with blue, green, red (iridium, platinum, osmium complexes) |
| 01/04/2011 | CA2468517C Thioether substituted imidazoquinolines |
| 01/04/2011 | CA2429312C Novel pyridine-substituted pyrazolopyridine derivatives |
| 12/30/2010 | US20100331360 3-substituted sulfonyl piperidine derivative |
| 12/30/2010 | US20100331325 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| 12/29/2010 | WO2010151006A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 12/29/2010 | WO2010150281A2 Novel azabicyclohexanes |
| 12/29/2010 | WO2010116142A3 Fluorophore and fluorescent sensor compound containing same |
| 12/29/2010 | EP2266959A1 8-carboxamido-substituted-2, 6-methano-3-benzazocines and 3-carboxamido-substituted morphanes as opioid receptor binding agents |
| 12/29/2010 | EP2265588A1 INHIBITORS OF 11ß -HYDROXYSTEROID DEHYDROGENASE TYPE 1 |
| 12/29/2010 | EP2265117A1 Inhibitors of protein phosphatase-1 and uses thereof |
| 12/29/2010 | CN1890326B Thermally stable anthrapyridone compositions |
| 12/29/2010 | CA2765692A1 Novel azabicyclohexanes |
| 12/28/2010 | US7858636 Use as coloring in coatings, printing inks and plastics, for producing aqueous polymer dispersions which absorb in the near infrared region, for producing markings which absorb infrared light and are invisible to the human eye, as infrared absorbers for heat management, active components in photovoltaics |
| 12/23/2010 | US20100324088 Fused Pyridone M1 Receptor Positive Allosteric Modulators |
| 12/23/2010 | US20100324080 Benzomorphan Compounds |
| 12/23/2010 | US20100324043 Bicyclic And Tricyclic Compounds As KAT II Inhibitors |
| 12/22/2010 | CN1988907B Dual small molecule inhibitors of cancer and angiogenesis |
| 12/22/2010 | CN101925658A Anthrapyridone compound or salt thereof, magenta ink composition containing anthrapyridone compound, and colored body |
| 12/22/2010 | CN101921711A Alternarlactam and preparation method and application thereof |
| 12/22/2010 | CN101921230A Preparation method of tertiary butyl 1-(aminomethyl)-6-azaspiro[2.5] octane-6-carboxylic ester |
| 12/22/2010 | CN101209994B Selectivity M4 acceptor antagonist and medical use thereof |
| 12/22/2010 | CN101072779B 2,4 (4,6) pyrimidine derivatives |
| 12/16/2010 | WO2010144640A2 Reductive amination of 6-keto normorphinans by catalytic hydrogen transfer |
| 12/16/2010 | US20100317861 Remove Amination of 6-Keto Normorphinans by Catalytic Hydrogen Transfer |
| 12/16/2010 | US20100317858 Metal coordination compound and light-emitting material containing the same |
| 12/15/2010 | CN101918420A Therapeutic cancer treatments |
| 12/14/2010 | CA2355939C Antihistaminic spiro compounds |
| 12/14/2010 | CA2347100C Novel indenoisoquinolines as antineoplastic agents |
| 12/14/2010 | CA2159546C Cycloalkano-indole and -azaindole derivatives |
| 12/09/2010 | US20100311734 Spiro Compounds Useful as Antagonists of the H1 Receptor |
| 12/08/2010 | EP2258688A1 Pyridinone derivatives for treatment of atherosclerosis |
| 12/08/2010 | EP1891011B1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5 |
| 12/08/2010 | EP1858857B1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists |
| 12/08/2010 | CN101239947B Method for preparing cryptotanshinone |
| 12/08/2010 | CN101139321B Method for separating and purifying nuciferine by employing cationic ion-exchange resin |
| 12/08/2010 | CN101134743B Method for extracting and separating Huperzine from huperzine serrate |
| 12/08/2010 | CN101056860B Method for producing perylene-3,4-dicarboxylic acid imides |
| 12/07/2010 | US7847125 additives for stabilizing organic products that are subject to oxidative, thermal, and/or light-induced degradation and in need of stabilization to prevent or inhibit such degradation, e.g., additives for lubricating oils that can improve the antioxidant properties of the oil |
| 12/07/2010 | CA2436409C Kappa opioid receptor ligands |
| 12/02/2010 | US20100303908 Pharmaceutical composition comprising desloratadine |
| 12/02/2010 | US20100303719 Anti-cancer compounds |
| 12/01/2010 | CN101899004A Sinomenine derivatives and preparation method and medical application thereof |
| 12/01/2010 | CN101591292B Method for synthesizing N-alkyl-3,4-perylene dianhydride carboxylic acid mono imide |
| 12/01/2010 | CN101445482B Method for synthesizing alkaloid |
| 12/01/2010 | CN101423495B Method for preparing aconitine hydrolysis monoesters alkaloids |
| 11/25/2010 | WO2010133569A1 Azabicyclo[4.1.0]heptane derivatives |
| 11/25/2010 | US20100298301 Oxazole tyrosine kinase inhibitors |
| 11/24/2010 | EP2252299A1 Fused pyridone m1 receptor positive allosteric modulators |
| 11/24/2010 | EP1280764B1 Inhibitors of histone deacetylase |
| 11/24/2010 | CN101896464A Sinomenine derivatives and processes for their synthesis |
| 11/24/2010 | CN101896463A Process and compounds for the production of (+) opiates |
| 11/23/2010 | US7838703 Diaromatic amine derivatives as antioxidants |
| 11/23/2010 | US7838677 Processes for preparing morphinans and intermediates thereof |
| 11/23/2010 | CA2480776C Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone |
| 11/18/2010 | WO2010132524A1 2-azatriphenylene materials for organic light emitting diodes |
| 11/18/2010 | WO2010130672A1 Azabicyclo [4.1.0] heptane derivatives and their use as monoamine reuptake inhibitors |
| 11/18/2010 | US20100291360 Anthrapyridone Compound Or A Salt Thereof, Magenta Ink Composition Containing The Anthrapyridone Compound and Colored Product |
| 11/18/2010 | US20100291020 Novel compounds as dipeptidyl peptidase iv (dpp iv) inhibitors |
| 11/17/2010 | EP2251330A1 4-Hydroxybenzomorphans |
| 11/17/2010 | EP2251327A2 Heterocyclic inhibitors of MEK and methods of use thereof |
| 11/17/2010 | EP1765770B1 Process for the preparation of gabapentin |
| 11/17/2010 | CN1907974B Huperzine with analgesic function and derivative thereof |
| 11/16/2010 | US7834184 Changing the substitution pattern on the aromatic ring of the pre-Grewe intermediate; 4-chloro-5-((1,2,3,4,5,8-hexahydro-6-methoxyisoquinolin-1-yl)methyl)benzene-1,2-diol; 4-chloro-5-(((R)-1,2,3,4,5,8-hexahydro-6-methoxyisoquinolin-1-yl)methyl)benzene-1,2-diol |
| 11/16/2010 | US7834016 breast cancer, prostate cancer, and colon cancer; indole, indoline, indol-2-one, or benzimidazoline based compounds having arylamine groups, for example 1-(pyrid-4-ylamino)-4-(2-(indol-3-yl)ethylamino)benzene |
| 11/16/2010 | US7833756 Methods of labelling polynucleotides with dibenzorhodamine dyes |
| 11/16/2010 | CA2477474C Cyclic n-substituted alpha imino carboxylic acids for selective inhibition of collagenase |
| 11/16/2010 | CA2436846C Thioether substituted imidazoquinolines |